Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE trial
ISRCTN91899513Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Feb 2009
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in prediabetes and coronary arteriosclerosis comparing Acarbose with Placebo (2 arms). Primary endpoint: Major cardiovascular events (MACE5). Started Feb 2009; status: completed.
02
Drugs
acarbose
03
Conditions
prediabetescoronary arteriosclerosis
Beyond the preview
Go deeper on ISRCTN91899513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91899513.